New antimalaria drug succeeds in first animal tests

August 29, 2001

Researchers at The Johns Hopkins University have designed a new drug for malaria that has easily passed the first stage of preclinical testing in mice and rats.

Scientists will announce their successful results in Chicago on August 29, 2001, at the American Chemical Society's annual summer meeting. The results will also appear as an expedited article in the September 2001 issue of the Journal of Medicinal Chemistry.

"The new compound is known as a carboxyphenyl trioxane, and its therapeutic index, the measure of a drug's safety and efficacy in treating a disease, is very good," says Gary Posner, Scowe Professor of Chemistry in the Krieger School of Arts and Sciences at Johns Hopkins. "In addition, it's water soluble and therefore easy to administer orally and intravenously."

Annually, malaria infects 300 million to 500 million people and causes 1.5 million to 3 million deaths. It is primarily spread by mosquito bites. The most commonly fatal strain of the malaria parasite is showing considerable resistance to current treatments, making development of new drugs a priority.

Posner worked with Theresa Shapiro, professor of Clinical Pharmacology at the Johns Hopkins School of Medicine, and co-workers Michael Parker, Heung Bae Jeon, Mikhail Krasavin, and Ik-Hyeon Paik to synthesize and test antimalarial drugs in the laboratory. Posner and Shapiro are active in the organization of the new $100 million Malaria Research Institute at the university's Bloomberg School of Public Health.

Posner, who will present at a symposium in Chicago called "Advances in controlling parasitic diseases," says results from first-stage testing of the drug's effectiveness and toxicity in mice and rats compared favorably to results from another water-soluble candidate for malaria treatment. That other drug is under development at the U.S. Walter Reed Army Institute of Research.

"There are some aspects where the Army's compound is better, and some where ours is better, and we hope that by showing that our carboxyphenyl trioxane has comparable potential, we'll receive support for further animal testing of it," says Posner.

Both compounds trace their roots to the work of Chinese organic chemists who 30 years ago isolated the pharmacologically active component of the plant artemisia, historically used by the Chinese as an herbal remedy for malaria.

With support from the National Institutes of Health since 1994, Posner's group has explored the details of how the active component of the herbal remedy fights malaria. Their research and that of other laboratories showed that the malaria parasite's metabolism creates products that react chemically with a peroxide (oxygen to oxygen) bond in the anti-malaria compound, generating harmful compounds such as oxidizing agents and carbon-free radicals that kill the parasite.

"Knowing the mechanistic details of how this happens gave us the insights we needed for rational design of new treatments," says Posner, who used his skills in what he calls "molecular architecture" to design molecules with improved malaria-fighting characteristics. The new carboxyphenyl trioxane is the best to emerge so far from hundreds of candidate molecules Posner's group has designed and synthesized.

Future plans include having a manufacturer produce a kilogram of the carboxyphenyl trioxane, which is completely synthetic, under "good manufacturing practice" conditions for testing in larger animals and in humans.
-end-
Related web site:
Posner group home page: http://www.jhu.edu/%7Echem/posner/index.html

THE JOHNS HOPKINS UNIVERSITY
OFFICE OF NEWS AND INFORMATION
3003 N. Charles Street, Suite 100
Baltimore, Maryland 21218-3843
Phone: 410-516-7160
Fax 410-516-5251

Johns Hopkins University

Related Malaria Articles from Brightsurf:

Clocking in with malaria parasites
Discovery of a malaria parasite's internal clock could lead to new treatment strategies.

Breakthrough in malaria research
An international scientific consortium led by the cell biologists Volker Heussler from the University of Bern and Oliver Billker from the UmeƄ University in Sweden has for the first time systematically investigated the genome of the malaria parasite Plasmodium throughout its life cycle in a large-scale experiment.

Scientists close in on malaria vaccine
Scientists have taken another big step forward towards developing a vaccine that's effective against the most severe forms of malaria.

New tool in fight against malaria
Modifying a class of molecules originally developed to treat the skin disease psoriasis could lead to a new malaria drug that is effective against malaria parasites resistant to currently available drugs.

Malaria expert warns of need for malaria drug to treat severe cases in US
The US each year sees more than 1,500 cases of malaria, and currently there is limited access to an intravenously administered (IV) drug needed for the more serious cases.

Monkey malaria breakthrough offers cure for relapsing malaria
A breakthrough in monkey malaria research by two University of Otago scientists could help scientists diagnose and treat a relapsing form of human malaria.

Getting to zero malaria cases in zanzibar
New research led by the Johns Hopkins Center for Communication Programs, Ifakara Health Institute and the Zanzibar Malaria Elimination Program suggests that a better understanding of human behavior at night -- when malaria mosquitoes are biting -- could be key to preventing lingering cases.

Widely used malaria treatment to prevent malaria in pregnant women
A global team of researchers, led by a research team at the Liverpool School of Tropical Medicine (LSTM), are calling for a review of drug-based strategies used to prevent malaria infections in pregnant women, in areas where there is widespread resistance to existing antimalarial medicines.

Protection against Malaria: A matter of balance
A balanced production of pro and anti-inflammatory cytokines at two years of age protects against clinical malaria in early childhood, according to a study led by ISGlobal, an institution supported by ''la Caixa'' Foundation.

The math of malaria
A new mathematical model for malaria shows how competition between parasite strains within a human host reduces the odds of drug resistance developing in a high-transmission setting.

Read More: Malaria News and Malaria Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.